Benzinga's Top Upgrades

Analysts at Credit Suisse upgraded USG USG from “underperform” to “neutral.” The target price for USG has been raised from $22 to $27. USG's stock closed at $24.55 on Friday. Analysts at Compass Point upgraded First Horizon National FHN from “sell” to “neutral.” The target price for First Horizon National has been raised from $9.50 to $10. First Horizon National's shares closed at $9.90 on Friday. JP Morgan upgraded Perrigo Company PRGO from “neutral” to “overweight.” The target price for Perrigo has been raised from $120 to $132. Perrigo's shares closed at $119.47 on Friday. Morgan Stanley upgraded AbbVie ABBV from “equal weight” to “overweight.” The target price for AbbVie has been raised from $36 to $49. AbbVie's shares closed at $42.39 on Friday.